Compare $CBIO vs $SGMT | Chartloom

Compare

$CBIO vs $SGMT

Crescent Biopharma Inc · Sagimet Biosciences Inc

CBIO

Crescent Biopharma Inc

SGMT

Sagimet Biosciences Inc

Compare $CBIO vs $SGMT

Comparing Crescent Biopharma Inc and Sagimet Biosciences Inc

CBIOCrescent Biopharma Inc

SGMTSagimet Biosciences Inc

CBIOCrescent Biopharma Inc

Market cap

$532M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

34.6%

52W performance

23.6%

FCF yield

-28.9%

SGMTSagimet Biosciences Inc

Market cap

$551M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

194.48x

Rev growth (TTM)

—

YTD performance

49.1%

52W performance

22.2%

FCF yield

-7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CBIO

SGMT

Detailed metrics comparison

CBIO

Crescent Biopharma Inc

SGMT

Sagimet Biosciences Inc

Market Cap

CBIO$532M

SGMT$551M

Enterprise Value

CBIO$360M

SGMT$386M

Price

CBIO$14.91

SGMT$8.93

P/E Ratio

CBION/A

SGMTN/A

P/S Ratio

CBIO44.76x

SGMT0.00x

EV/Sales

CBIO30.32x

SGMT0.00x

EV/EBITDA

CBIO0.00x

SGMT0.00x

P/B Ratio

CBIO3.26x

SGMT2.20x

P/FCF Ratio

CBION/A

SGMTN/A

EV/FCF

CBIO-2.35x

SGMT-9.24x

PEG Ratio

CBION/A

SGMTN/A

Forward P/E (NTM)

CBION/A

SGMTN/A

Forward P/S (NTM)

CBION/A

SGMT194.48x

Revenue (TTM)

CBIO$12M

SGMT$0

Revenue Growth (YoY)

CBION/A

SGMTN/A

Forward Rev Growth

CBIO-15.7%

SGMT89.0%

Gross Margin (TTM)

CBIO0.0%

SGMT0.0%

Operating Margin (TTM)

CBIO0.0%

SGMT0.0%

EBITDA Margin (TTM)

CBIO-1355.3%

SGMT0.0%

Net Margin (TTM)

CBIO-1406.4%

SGMT0.0%

FCF Margin (TTM)

CBIO-1292.8%

SGMTN/A

Net Income (TTM)

CBIO$-167M

SGMT$-47M

FCF (TTM)

CBIO$-154M

SGMT$-42M

EPS (TTM)

CBIO-$5.47

SGMT-$0.89

ROE (TTM)

CBIO-10026.0%

SGMT-3196.0%

ROA (TTM)

CBIO-8791.0%

SGMT-3057.0%

ROIC (TTM)

CBIO-10026.0%

SGMT-3196.0%

Cash

CBIO$172M

SGMT$166M

Debt

CBIO$0

SGMT$0

Net Cash/Debt

CBIO$172M

SGMT$166M

Current Ratio (TTM)

CBIO9.66x

SGMT45.02x

Quick Ratio (TTM)

CBIO9.26x

SGMT44.43x

Debt/Equity (TTM)

CBIO0.00x

SGMT0.00x

Debt/Assets (TTM)

CBIO0.0%

SGMT0.0%

Interest Coverage (TTM)

CBION/A

SGMTN/A

Net Debt/EBITDA (TTM)

CBIO0.00x

SGMT0.00x

Beta

CBIO1.39

SGMT3.54

52W Performance

CBIO23.6%

SGMT22.2%

YTD Performance

CBIO34.6%

SGMT49.1%

% from 52W High

CBIO-45.6%

SGMT-22.0%

% from 52W Low

CBIO71.0%

SGMT98.4%

Asset Turnover (TTM)

CBIO0.05x

SGMT0.00x

FCF Yield (TTM)

CBIO-28.9%

SGMT-7.6%

Earnings Yield (TTM)

CBIO-31.4%

SGMT-8.5%

Dividend Yield (TTM)

CBION/A

SGMTN/A

Rule of 40

CBIO-1,292.8

SGMT0.0

EV/GP/RG

CBION/A

SGMTN/A

Ticker research

View CBIO research View SGMT research

Metric	CBIO Crescent Biopharma Inc	SGMT Sagimet Biosciences Inc
Market & Valuation
Market Cap	$532M	$551M
Enterprise Value	$360M	$386M
Price	$14.91	$8.93
P/E Ratio	N/A	N/A
P/S Ratio	44.76x	0.00x
EV/Sales	30.32x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.26x	2.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.35x	-9.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	194.48x
Revenue & Growth
Revenue (TTM)	$12M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-15.7%	89.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1355.3%	0.0%
Net Margin (TTM)	-1406.4%	0.0%
FCF Margin (TTM)	-1292.8%	N/A
Net Income (TTM)	$-167M	$-47M
FCF (TTM)	$-154M	$-42M
EPS (TTM)	-$5.47	-$0.89
ROE (TTM)	-10026.0%	-3196.0%
ROA (TTM)	-8791.0%	-3057.0%
ROIC (TTM)	-10026.0%	-3196.0%
Financial Health
Cash	$172M	$166M
Debt	$0	$0
Net Cash/Debt	$172M	$166M
Current Ratio (TTM)	9.66x	45.02x
Quick Ratio (TTM)	9.26x	44.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	3.54
52W Performance	23.6%	22.2%
YTD Performance	34.6%	49.1%
% from 52W High	-45.6%	-22.0%
% from 52W Low	71.0%	98.4%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-28.9%	-7.6%
Earnings Yield (TTM)	-31.4%	-8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,292.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CBIO research	View SGMT research

Valuation

P/S Ratio

SGMT

0.00x

CBIO

44.76x

EV/FCF

SGMT

-9.24x

CBIO

-2.35x

Growth & revenue

Forward Revenue Growth

SGMT

89.0%

CBIO

-15.7%

Profitability & performance

Gross Margin

CBIO

0.0%

SGMT

0.0%

ROE

SGMT

-3196.0%

CBIO

-10026.0%

FCF Yield %

SGMT

-7.6%

CBIO

-28.9%

52-Week Performance

CBIO

23.6%

SGMT

22.2%

Detailed metrics comparison

CBIO

Crescent Biopharma Inc

SGMT

Sagimet Biosciences Inc

Market Cap

CBIO$532M

SGMT$551M

Enterprise Value

CBIO$360M

SGMT$386M

Price

CBIO$14.91

SGMT$8.93

P/E Ratio

CBION/A

SGMTN/A

P/S Ratio

CBIO44.76x

SGMT0.00x

EV/Sales

CBIO30.32x

SGMT0.00x

EV/EBITDA

CBIO0.00x

SGMT0.00x

P/B Ratio

CBIO3.26x

SGMT2.20x

P/FCF Ratio

CBION/A

SGMTN/A

EV/FCF

CBIO-2.35x

SGMT-9.24x

PEG Ratio

CBION/A

SGMTN/A

Forward P/E (NTM)

CBION/A

SGMTN/A

Forward P/S (NTM)

CBION/A

SGMT194.48x

Revenue (TTM)

CBIO$12M

SGMT$0

Revenue Growth (YoY)

CBION/A

SGMTN/A

Forward Rev Growth

CBIO-15.7%

SGMT89.0%

Gross Margin (TTM)

CBIO0.0%

SGMT0.0%

Operating Margin (TTM)

CBIO0.0%

SGMT0.0%

EBITDA Margin (TTM)

CBIO-1355.3%

SGMT0.0%

Net Margin (TTM)

CBIO-1406.4%

SGMT0.0%

FCF Margin (TTM)

CBIO-1292.8%

SGMTN/A

Net Income (TTM)

CBIO$-167M

SGMT$-47M

FCF (TTM)

CBIO$-154M

SGMT$-42M

EPS (TTM)

CBIO-$5.47

SGMT-$0.89

ROE (TTM)

CBIO-10026.0%

SGMT-3196.0%

ROA (TTM)

CBIO-8791.0%

SGMT-3057.0%

ROIC (TTM)

CBIO-10026.0%

SGMT-3196.0%

Cash

CBIO$172M

SGMT$166M

Debt

CBIO$0

SGMT$0

Net Cash/Debt

CBIO$172M

SGMT$166M

Current Ratio (TTM)

CBIO9.66x

SGMT45.02x

Quick Ratio (TTM)

CBIO9.26x

SGMT44.43x

Debt/Equity (TTM)

CBIO0.00x

SGMT0.00x

Debt/Assets (TTM)

CBIO0.0%

SGMT0.0%

Interest Coverage (TTM)

CBION/A

SGMTN/A

Net Debt/EBITDA (TTM)

CBIO0.00x

SGMT0.00x

Beta

CBIO1.39

SGMT3.54

52W Performance

CBIO23.6%

SGMT22.2%

YTD Performance

CBIO34.6%

SGMT49.1%

% from 52W High

CBIO-45.6%

SGMT-22.0%

% from 52W Low

CBIO71.0%

SGMT98.4%

Asset Turnover (TTM)

CBIO0.05x

SGMT0.00x

FCF Yield (TTM)

CBIO-28.9%

SGMT-7.6%

Earnings Yield (TTM)

CBIO-31.4%

SGMT-8.5%

Dividend Yield (TTM)

CBION/A

SGMTN/A

Rule of 40

CBIO-1,292.8

SGMT0.0

EV/GP/RG

CBION/A

SGMTN/A

Ticker research

View CBIO research View SGMT research

Metric	CBIO Crescent Biopharma Inc	SGMT Sagimet Biosciences Inc
Market & Valuation
Market Cap	$532M	$551M
Enterprise Value	$360M	$386M
Price	$14.91	$8.93
P/E Ratio	N/A	N/A
P/S Ratio	44.76x	0.00x
EV/Sales	30.32x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.26x	2.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.35x	-9.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	194.48x
Revenue & Growth
Revenue (TTM)	$12M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-15.7%	89.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1355.3%	0.0%
Net Margin (TTM)	-1406.4%	0.0%
FCF Margin (TTM)	-1292.8%	N/A
Net Income (TTM)	$-167M	$-47M
FCF (TTM)	$-154M	$-42M
EPS (TTM)	-$5.47	-$0.89
ROE (TTM)	-10026.0%	-3196.0%
ROA (TTM)	-8791.0%	-3057.0%
ROIC (TTM)	-10026.0%	-3196.0%
Financial Health
Cash	$172M	$166M
Debt	$0	$0
Net Cash/Debt	$172M	$166M
Current Ratio (TTM)	9.66x	45.02x
Quick Ratio (TTM)	9.26x	44.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	3.54
52W Performance	23.6%	22.2%
YTD Performance	34.6%	49.1%
% from 52W High	-45.6%	-22.0%
% from 52W Low	71.0%	98.4%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-28.9%	-7.6%
Earnings Yield (TTM)	-31.4%	-8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,292.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CBIO research	View SGMT research